Table 3.
Clinical symptoms and laboratory data in patients
| Laboratory values | Before IVT initiation | After discontinuing IVT | P-value |
|---|---|---|---|
| Temperature >38°C | 25/25 (100%) | 4/25 (16%) | |
| Neck stiffness | 16/25 (64%) | 3/25 (12%) | |
| Changing level of consciousness | Deterioration | Improvements | |
| 25/25 (100%) | 21/25 (84%) | ||
| CSF leukocyte count | |||
| Median ± IQR, cells/mm3 (range) | 1,030±12,100 (20–106,670) | 10±11.5 (1–220) | <0.05 |
| <100 | 3/25 (12) | 23/25 (92) | |
| 100–999 | 10/25 (40) | 2/25 (8) | |
| >999 | 12/25 (48) | 0 | |
| CSF glucose | |||
| Mean ± SD, mmol/L (range) | 1.42±0.53 (1.1–2.5) | 3.30±1.03(1.1–5.4) | <0.05 |
| <1.9 | 19/25 (76) | 1/25 (4) | |
| ≧1.9 | 6/25 (24) | 24/25 (96) | |
| CSF/blood glucose | |||
| Mean ± SD (range) | 0.22±0.10 (0.10–0.51) | 0.54±0.19 (0.25–1) | P<0.05 |
| <0.23 | 17/25 (68) | 1/25 (4) | |
| ≧0.23 | 8/25 (32) | 24/25 (96) | |
| CSF protein | |||
| Mean ± SD, g/L | 2.79±0.59 (0.85–3) | 1.52±0.99 (0.1–3) | P<0.05 |
| >2.2 | 22/25 (88) | 4/25 (16) | |
| ≤2.2 | 3/25 (12) | 19/25 (84) |
Abbreviations: CSF, cerebrospinal fluid; IVT, intraventricular; IQR, interquartile.